VirMedica to Present at CBI’s 6th HUB and SPP Model Optimization Conference
February 22, 2016 – Philadelphia, Pa. – VirMedica, the leader in providing e-access technology solutions designed to expedite patient access to biopharmaceutical products, today announced that the Company will be participating in CBI’s 6th HUB and SPP Model Optimization Conference.
CBI’s Hub Model Conference Series brings together esteemed leaders in patient access, brand management, reimbursement and specialty distribution across the healthcare industry and focuses on breakthrough strategies and service model design and enhancement to improve access and outcomes.
John H. Johnson appointed as Executive Chairman of the Board
November 9, 2015 – Philadelphia, Pa. – VirMedica, the leader in providing e-access technology solutions, announced the appointment of John H. Johnson as executive chairman.
John H. Johnson is a recognized leader in the biopharmaceutical industry with more than 30 years of experience at leading global organizations, including Johnson & Johnson, Eli Lilly & Company, ImClone and Pfizer, Inc. He currently serves as chairman of Strongbridge Biopharma plc, and as a member of the board of directors of Cempra Pharmaceuticals, Inc., Histogenics Corporation, Portola Pharmaceuticals, Inc., and Sucampo Pharmaceuticals, Inc. He previously served as a member of the board of directors of Pharmaceutical Research and Manufacturers of America (PhRMA), the Health Section Governing Board of Biotechnology Industry Organizations (BIO), and BioNJ.
VirMedica Makes Capital Investment in D2 Pharma Consulting
February 19, 2015 – Philadelphia, PA – VirMedica, a leading provider of technology solutions designed to optimize the commercialization of specialty pharmaceutical products, announced today that it has made a significant capital investment in D2 Pharma Consulting, LLC (“D2”). D2 is an independent consulting firm offering a broad range of commercialization services for manufacturers and service providers in the life sciences industry.
VirMedica Continues to Expand Capabilities through Acquiring Assets of TransEngen, Inc.
February 19, 2015 – Philadelphia, PA. – VirMedica, a leading provider of technology solutions designed to optimize the commercialization of specialty pharmaceutical products, announced today that VirMedica, Inc. (“VirMedica”) has acquired the assets of TransEngen, Inc.